http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 22 Jul 2026 09:50:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Sanofi+++++++++++++++++++++++++++++++++Filed+by%3A+Amundi/26799622.html si-local-file:///var/storage/secattach/20260722/26799622.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Sanofi+++++++++++++++++++++++++++++++++Filed+by%3A+Amundi/26799622.html Wed, 22 Jul 2026 09:50:00 -0400 O.00356206 SAN SNY http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Sanofi+++++++++++++++++++++++++++++++++Filed+by%3A+Amundi/26799622.html si-local-file:///var/storage/secattach/20260722/26799622.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Sanofi+++++++++++++++++++++++++++++++++Filed+by%3A+Amundi/26799622.html Wed, 22 Jul 2026 09:50:00 -0400 O.00356206 SAN SNY http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Sanofi+++++++++++++++++++++++++++++++++Filed+by%3A+Amundi/26799622.html si-local-file:///var/storage/secattach/20260722/26799622.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Sanofi+++++++++++++++++++++++++++++++++Filed+by%3A+Amundi/26799622.html Wed, 22 Jul 2026 09:50:00 -0400 O.00356206 SAN SNY http://www.streetinsider.com/Board+Changes/Sanofi+reshapes+executive+committee+effective+September+2026/26794502.html <p>Sanofi (EURONEXT: SAN, NASDAQ: SNY) announced a restructuring of its Executive Committee, with changes taking effect September 1, 2026, according to a company statement.</p><p>The revised committee will include eight members: François Roger as Executive Vice President of Finance; Paulo Fontoura as Executive Vice President and Head of Research & Development; Manuela Buxo as Executive Vice President of Specialty Care; Thomas Triomphe as Executive Vice President of Vaccines; Thomas Grenier as Executive Vice President of General Medicines; Brendan O'Callaghan as Executive Vice President of Manufacturing & Supply; Jamie Haney as Executive Vice President and General Counsel; and Véronique Jaillet as Executive http://www.streetinsider.com/Board+Changes/Sanofi+reshapes+executive+committee+effective+September+2026/26794502.html Tue, 21 Jul 2026 12:05:36 -0400 SAN SNY http://www.streetinsider.com/Board+Changes/Sanofi+reshapes+executive+committee+effective+September+2026/26794502.html <p>Sanofi (EURONEXT: SAN, NASDAQ: SNY) announced a restructuring of its Executive Committee, with changes taking effect September 1, 2026, according to a company statement.</p><p>The revised committee will include eight members: François Roger as Executive Vice President of Finance; Paulo Fontoura as Executive Vice President and Head of Research & Development; Manuela Buxo as Executive Vice President of Specialty Care; Thomas Triomphe as Executive Vice President of Vaccines; Thomas Grenier as Executive Vice President of General Medicines; Brendan O'Callaghan as Executive Vice President of Manufacturing & Supply; Jamie Haney as Executive Vice President and General Counsel; and Véronique Jaillet as Executive http://www.streetinsider.com/Board+Changes/Sanofi+reshapes+executive+committee+effective+September+2026/26794502.html Tue, 21 Jul 2026 12:05:36 -0400 SAN SNY http://www.streetinsider.com/Corporate+News/Sanofi+reshapes+executive+committee+effective+September+2026/26794502.html <p>Sanofi (EURONEXT: SAN, NASDAQ: SNY) announced a restructuring of its Executive Committee, with changes taking effect September 1, 2026, according to a company statement.</p><p>The revised committee will include eight members: François Roger as Executive Vice President of Finance; Paulo Fontoura as Executive Vice President and Head of Research & Development; Manuela Buxo as Executive Vice President of Specialty Care; Thomas Triomphe as Executive Vice President of Vaccines; Thomas Grenier as Executive Vice President of General Medicines; Brendan O'Callaghan as Executive Vice President of Manufacturing & Supply; Jamie Haney as Executive Vice President and General Counsel; and Véronique Jaillet as Executive http://www.streetinsider.com/Corporate+News/Sanofi+reshapes+executive+committee+effective+September+2026/26794502.html Tue, 21 Jul 2026 12:05:36 -0400 SAN SNY http://www.streetinsider.com/Corporate+News/Sanofi+reshapes+executive+committee+effective+September+2026/26794502.html <p>Sanofi (EURONEXT: SAN, NASDAQ: SNY) announced a restructuring of its Executive Committee, with changes taking effect September 1, 2026, according to a company statement.</p><p>The revised committee will include eight members: François Roger as Executive Vice President of Finance; Paulo Fontoura as Executive Vice President and Head of Research & Development; Manuela Buxo as Executive Vice President of Specialty Care; Thomas Triomphe as Executive Vice President of Vaccines; Thomas Grenier as Executive Vice President of General Medicines; Brendan O'Callaghan as Executive Vice President of Manufacturing & Supply; Jamie Haney as Executive Vice President and General Counsel; and Véronique Jaillet as Executive http://www.streetinsider.com/Corporate+News/Sanofi+reshapes+executive+committee+effective+September+2026/26794502.html Tue, 21 Jul 2026 12:05:36 -0400 SAN SNY http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Press+Releases/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html <p align="justify"><i>Sanofi evolves its Executive Committee to support its next strategic chapter</i></p> <p align="justify"><b>Paris, July 21, 2026</b>. Sanofi today announced an evolution of its Executive Committee, bringing together a focused leadership team across its businesses, scientific organization and key global functions as the company continues to deliver on its priorities and prepares its next strategic chapter.</p> <p align="justify">Effective September 1, 2026, Sanofi&apos;s Executive Committee will comprise: </p> <ul><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">François Roger, Executive Vice President, Finance </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Paulo Fontoura, Executive Vice President, Head of Research &amp; Development </li><li style="margin-top:0cm; margin-bottom:0cm; text-align:justify;">Manuela Buxo, Executive Vice President, http://www.streetinsider.com/Globe+Newswire/Press+Release%3A+Sanofi+evolves+its+Executive+Committee+to+support+its+next+strategic+chapter/26794478.html Tue, 21 Jul 2026 12:00:00 -0400 A.22211465 A.50216984 O.00356206 O.54450828 O.73873319 SAN SNY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Jul+17/26781546.html si-local-file:///var/storage/secattach/20260717/26781546.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Jul+17/26781546.html Fri, 17 Jul 2026 06:04:00 -0400 O.00356206 SAN SNY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Jul+17/26781546.html si-local-file:///var/storage/secattach/20260717/26781546.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Jul+17/26781546.html Fri, 17 Jul 2026 06:04:00 -0400 O.00356206 SAN SNY http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Jul+17/26781546.html si-local-file:///var/storage/secattach/20260717/26781546.html http://www.streetinsider.com/SEC+Filings/Form++6-K++++++++Sanofi++++++++++++++++++++For%3A+Jul+17/26781546.html Fri, 17 Jul 2026 06:04:00 -0400 O.00356206 SAN SNY http://www.streetinsider.com/Reuters/US+FDA+approves+Sanofi%27s+wearable+injector+form+of+blood+cancer+drug/26755541.html <p>By Sneha S K ‌and Bhanvi Satija</p> <p>July ​10 (Reuters) - ​The U.S. Food and Drug Administration said on Friday it has approved a wearable form of Sanofi's blood cancer drug, Sarclisa, ‌offering multiple myeloma patients a less burdensome alternative to intravenous ⁠infusions.</p> <p>It is the first cancer drug approved by the FDA that can be delivered through ‌an on-body http://www.streetinsider.com/Reuters/US+FDA+approves+Sanofi%27s+wearable+injector+form+of+blood+cancer+drug/26755541.html Fri, 10 Jul 2026 08:56:10 -0400 SNY